Suppr超能文献

美国医院表皮葡萄球菌临床分离株的分子流行病学研究。

Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.

机构信息

JMI Laboratories, North Liberty, Iowa, USA.

出版信息

Antimicrob Agents Chemother. 2012 Sep;56(9):4656-61. doi: 10.1128/AAC.00279-12. Epub 2012 Jun 11.

Abstract

The epidemiology of Staphylococcus epidermidis in U.S. hospitals remains limited. This study aimed to address the genetic backgrounds of linezolid-susceptible and -resistant S. epidermidis strains (isolated in 2010), including cfr-carrying strains. In addition, the antimicrobial susceptibility profiles and linezolid resistance mechanisms among clonal lineages were assessed. A total of 71 S. epidermidis isolates were selected, and linezolid-resistant strains were screened for cfr and mutations in 23S rRNA, L3, and L4. All isolates were subjected to multilocus sequence typing (MLST), and the results were analyzed by eBURST. Overall, 27 sequence types (STs) were detected, and ST5 (21.1%) and ST2 (16.9%) predominated. The majority (62/71; 87.3%) of STs belonged to clonal complex 2 (CC2), which was mostly comprised of subclusters CC2-II (41/62; 66.1%) and CC2-I (21/62; 33.9%). Other STs were grouped within CC23 or CC32 or were singletons. CC2-I strains were more likely to display a methicillin (95.2% versus 33.3 to 70.7%), a linezolid (47.6% versus 0.0 to 7.3%), or a multidrug (81.0% versus 33.3 to 36.6%) resistance phenotype. Among linezolid-resistant isolates, cfr was noted only within CC2 strains, and it was detected equally in the CC2-I (3/10; 30.0%) and CC2-II (1/3; 33.3%) subclusters. 23S rRNA mutations (G2576 [seven strains] and C2534 [one strain]) were observed only among CC2-I (8/10; 80.0%) isolates. Strains showing a G2576 alteration also had M156 (7/7; 100.0%) and/or H146 (6/7; 85.7%) L3 modifications. This study provides an overview of the S. epidermidis clonal distribution and reports higher resistance rates among CC2-I strains. The results show that cfr may be acquired and expressed by both CC2 main subclusters, while 23S rRNA mutations appeared more often within CC2-I strains. Interestingly, these 23S rRNA mutants also had L3 alterations, which may act synergistically or in a compensatory manner to minimize the fitness cost while providing survival advantages under selective pressure.

摘要

美国医院中表皮葡萄球菌的流行病学仍然有限。本研究旨在探讨利奈唑胺敏感和耐药表皮葡萄球菌(2010 年分离)的遗传背景,包括携带 cfr 的菌株。此外,还评估了克隆谱系中的抗菌药物敏感性谱和利奈唑胺耐药机制。共选择了 71 株表皮葡萄球菌分离株,筛选了利奈唑胺耐药株中 cfr 和 23S rRNA、L3 和 L4 中的突变。所有分离株均进行多位点序列分型(MLST),并通过 eBURST 进行分析。总体而言,检测到 27 种序列类型(ST),ST5(21.1%)和 ST2(16.9%)占主导地位。大多数 ST(71/71;87.3%)属于克隆复合体 2(CC2),其中主要由亚群 CC2-II(41/62;66.1%)和 CC2-I(21/62;33.9%)组成。其他 ST 属于 CC23 或 CC32 或为单克隆。CC2-I 菌株更可能表现出耐甲氧西林(95.2%比 33.3%至 70.7%)、利奈唑胺(47.6%比 0.0%至 7.3%)或多药耐药(81.0%比 33.3%至 36.6%)表型。在耐利奈唑胺的分离株中,仅在 CC2 菌株中发现 cfr,在 CC2-I(3/10;30.0%)和 CC2-II(1/3;33.3%)亚群中检测到的 cfr 数量相等。仅在 CC2-I(8/10;80.0%)分离株中观察到 23S rRNA 突变(G2576[7 株]和 C2534[1 株])。表现出 G2576 改变的菌株也具有 M156(7/7;100.0%)和/或 H146(6/7;85.7%)L3 修饰。本研究概述了表皮葡萄球菌的克隆分布,并报告了 CC2-I 菌株更高的耐药率。结果表明,cfr 可能由 CC2 的两个主要亚群获得和表达,而 23S rRNA 突变在 CC2-I 菌株中更为常见。有趣的是,这些 23S rRNA 突变体也具有 L3 改变,这可能以协同或补偿的方式发挥作用,以在选择性压力下最小化适应性成本,同时提供生存优势。

相似文献

1
Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.
Antimicrob Agents Chemother. 2012 Sep;56(9):4656-61. doi: 10.1128/AAC.00279-12. Epub 2012 Jun 11.
3
Mechanisms of Linezolid Resistance Among Clinical spp. in Spain: Spread of Methicillin- and Linezolid-Resistant ST2.
Microb Drug Resist. 2021 Feb;27(2):145-153. doi: 10.1089/mdr.2020.0122. Epub 2020 May 22.
10
Polyphyletic emergence of linezolid-resistant staphylococci in the United States.
Antimicrob Agents Chemother. 2010 Feb;54(2):742-8. doi: 10.1128/AAC.00621-09. Epub 2009 Nov 23.

引用本文的文献

1
D-alanylation of lipoteichoic acids inhibitor provides anti-virulence and anti-resistance effects against methicillin-resistant .
Antimicrob Agents Chemother. 2025 May 7;69(5):e0182224. doi: 10.1128/aac.01822-24. Epub 2025 Mar 21.
4
Characterization of the resistome and predominant genetic lineages of Gram-positive bacteria causing keratitis.
Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0124723. doi: 10.1128/aac.01247-23. Epub 2024 Jan 30.
5
Epidemiology of neonatal sepsis in two neonatal intensive care units in Krakow, Poland in 2016-2017 years.
BMC Infect Dis. 2023 Nov 24;23(1):827. doi: 10.1186/s12879-023-08836-2.
7
Molecular epidemiology and characterization of antimicrobial-resistant strains isolated from dairy cattle milk in Northwest, China.
Front Cell Infect Microbiol. 2023 May 17;13:1183390. doi: 10.3389/fcimb.2023.1183390. eCollection 2023.
8
Difficult-to-Treat Pathogens: A Review on the Management of Multidrug-Resistant .
Life (Basel). 2023 May 4;13(5):1126. doi: 10.3390/life13051126.
10
Molecular Detection and Characterization of the and Isolated from Hospitalized Patients and Healthcare Workers in Iran.
Biomed Res Int. 2023 Jan 6;2023:3775142. doi: 10.1155/2023/3775142. eCollection 2023.

本文引用的文献

1
Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis.
Antimicrob Agents Chemother. 2012 Jul;56(7):3917-22. doi: 10.1128/AAC.00419-12. Epub 2012 Apr 9.
3
The oxazolidinones: past, present, and future.
Ann N Y Acad Sci. 2011 Dec;1241:48-70. doi: 10.1111/j.1749-6632.2011.06330.x.
4
Resistance to linezolid caused by modifications at its binding site on the ribosome.
Antimicrob Agents Chemother. 2012 Feb;56(2):603-12. doi: 10.1128/AAC.05702-11. Epub 2011 Dec 5.
6
Detection of the staphylococcal multiresistance gene cfr in Proteus vulgaris of food animal origin.
J Antimicrob Chemother. 2011 Nov;66(11):2521-6. doi: 10.1093/jac/dkr322. Epub 2011 Jul 26.
8
Low fitness cost of the multidrug resistance gene cfr.
Antimicrob Agents Chemother. 2011 Aug;55(8):3714-9. doi: 10.1128/AAC.00153-11. Epub 2011 Jun 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验